← Leaderboards
Anton V. Borovjagin
University Of Alabama At Birmingham
$219,750
Attributed
$219,750
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $109.9K · FY2011–12$200K$150K$100K$50K$0
'11
'12
Funding mix
By agency
NIH$219,750 · 1
By mechanism
R03$219,750 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- David T Curiel$31,690,411
- Richard J. Whitley$15,110,969
- Erwin G Van Meir$28,591,922
- Ralph R Weichselbaum$16,065,057
- Jason Morgan Warram$3,373,796
Others in their field
Top investigators on “Animal Cancer Model”
- David Heimbrook · Leidos Biomedical Research, Inc.$472,074,973
- Leonard Freedman · Leidos Biomedical Research, Inc.$65,587,215
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$45,644,409
- Neil Scott Lipman · Sloan-Kettering Inst Can Research$39,869,247
- Evan Todd Keller · University Of Michigan At Ann Arbor$29,595,602
- Rakesh K. Jain · Massachusetts General Hospital$29,562,157
Research focus
Animal Cancer ModelAnimal ModelAntibodiesAntibody TherapyAnti-Cancer TherapeuticAntineoplastic AgentsApoptosisAreaBaseBiodistributionBioluminescenceBiomarkerBloodCancer CellCancer TherapyCapsidCapsid ProteinsCellsCetuximabClinical EfficacyCommon TreatmentConditionally Replicative AdenovirusCxcr4 GeneAdenoviruses